Загрузка...
Efficacy and safety of apatinib combined with transarterial chemoembolization (TACE) in treating patients with recurrent hepatocellular carcinoma
BACKGROUND: Apatinib, a vascular endothelial growth factor receptor 2 (VEGFR-2) inhibitor, has shown promising therapeutic effect for hepatocellular carcinoma (HCC). This prospective clinical study was implemented to evaluate the efficacy and safety of apatinib combined with transarterial chemoembol...
Сохранить в:
| Опубликовано в: : | Ann Transl Med |
|---|---|
| Главные авторы: | , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
AME Publishing Company
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7812192/ https://ncbi.nlm.nih.gov/pubmed/33490189 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm-20-7244 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|